retatrutide and joint pain (Eli Lilly's triple GLP-1/GIP/Glucagon receptor agonist) just delivered the most impressive obesity + osteoarthritis data we've ever seen in the phase 3 TRIUMPH-4 trial: Retatrutide: Is It The Next

Although studies in animal models have shown that GLP-1R agonists reduce Aaccumulation and tau hyperphosphorylation, few human studies have evaluated these effects

Taking L-glutathione is a fantastic step, but it shouldn't be the only one

When you're in a deficit, recovery can take longer

PASC: viral-hijacked host cellular factors and consequences The initial step of COVID-19 pathogenesis involves that the viral spike (S)-protein interacts and anchors to susceptible host tissue by hijacking of specific CSRs (i.e., ACE2 and NRP1)

Severe Conditions that can lead to severe glutathione depletion have been listed

, , , ,